Ascorbic acid compositions providing enhanced human immune system activity
US5626883A · kind A · utility
54Cited by
2References
34Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 15, 1994 |
| Grant date | May 6, 1997 |
| Priority date | — |
| Expiry date | Apr 15, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A vitamin C supplement comprising ascorbic acid, ascorbyl palmitate, niacinamide ascorbate, calcium ascorbate, magnesium ascorbate, potassium ascorbate, and sodium ascorbate which together can be administered to a human to avoid the transitory initial suppression of human NK cell activity which is present when ascorbic acid alone is administered. Also included is xylitol, lysine acetate, tetrasodium pyrophosphate, ribose, cysteine, and hesperidin which further prolongs the biological activity of ascorbic acid and promotes the uptake of ascorbic acid by human tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.